ENOV Enovis Corporation
Enovis Corporation (ENOV) is expected to report earnings on November 5, 2026, before the market open. The consensus earnings estimate is $0.69 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -9.7% since its last earnings release on August 6, 2026.
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About Enovis Corporation
Enovis Corporation is an innovation-driven medical technology growth company dedicated to developing clinically differentiated solutions that generate measurably better patient outcomes and transform workflows.
Sector
Healthcare
Industry
Medical Instruments/Supply